Open AccessBy the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
Author(s) -
Richard R. Love
Publication year - 2021
Publication title -
archives of breast cancer
Language(s) - English
Resource type - Journals
eISSN - 2383-0433
pISSN - 2383-0425
DOI - 10.32768/abc.2021818-13
Subject(s) - tamoxifen , oophorectomy , breast cancer , medicine , gynecology , adjuvant , oestrogen receptor , hormone , oncology , hormone receptor , cancer , hysterectomy , surgery
NA
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom